Extensive studies further demonstrate that FZD2 overexpression induces oncogenic phenotypes across multiple cancers, including glioma and gastric cancer (Tomizawa et al., 2015; Bian et al., 2016; Tomizawa et al., 2016; Fu et al., 2020). The gene discussed is FZD2; the disease is central nervous system cancer.